New Paradigm Investment (Co-CEOs Sang-Seung Bae and Je-Hyeon Park) announced on the 1st that it had made a seed investment in CuraPulse (CEO Nam-Gyu Cho), a beauty tech startup developing skin cell regeneration technology.
Curapulse focuses on developing high-performance home beauty devices based on non-invasive skin regeneration technology utilizing complex energies such as ultrasound, pulses, and light. The company is pursuing the commercialization of skin beauty devices through proprietary ultrasound remote focusing technology and multi-crossover ultrasound drive and analysis technology. It also continuously accumulates preclinical and human clinical data to enhance its technological reliability.
Key technologies include 'WaveSync™', a skin regeneration technology through cell stimulation, 'DualPoration™', which increases the skin penetration rate of effective ingredients, and 'IntraSonix™', which improves the body's absorption rate of orally ingested ingredients. These technologies have been applied to the flagship product, the 'DualTetra' series, and are receiving positive responses in the market.
Park Jae-hyun, co-CEO of New Paradigm Investment, explained, “Curapulse is a beauty tech company with differentiated competitiveness based on technology-centered product design and empirical data,” and “We decided to invest because we highly value its expandability and technological innovation potential in the global market beyond K-beauty.”
Curapulse plans to launch a new, cost-effective home beauty device by the end of the year and is currently in OEM/ODM negotiations for entry into the European and North American markets. In Japan, the company has completed a product introduction to local buyers at the Toyota Tsusho Show, and initial sales have begun in the US. Furthermore, the company is actively expanding its B2C channel through influencer marketing (MCN) and entering the Greater China market.
“We will grow into a global beauty tech company that improves skin health with technology based on scientific evidence,” said Nam-gyu Cho, CEO of Curapulse. “This investment will further accelerate product advancement and overseas expansion.”
- See more related articles
You must be logged in to post a comment.